PCORI funds more than $150 million to support new patient-centered clinical effectiveness research

NewsGuard 100/100 Score

The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling more than $150 million to support new patient-centered comparative clinical effectiveness research (CER) studies, research to strengthen the rigor and quality of patient-centered CER and a project to implement the findings of PCORI-funded research into practice.

Among the nine awards for patient-centered CER, two include support for large, two-phased trials comparing approaches to treatments for heart failure and asthma. Two other large studies will compare health system strategies to improve hypertension control, and another will evaluate the effectiveness of medications used for migraine prevention.

As a leading funder of patient-centered comparative clinical effectiveness research, PCORI recognizes the evidence generated from PCORI-funded research helps patients and those who care for them make informed decisions about which health care options will work best for them. These latest awards present significant opportunities to fill important evidence gaps across a broad range of health conditions facing millions of people living in the United States every day."

Nakela L. Cook, M.D., MPH, PCORI Executive Director 

This latest round of PCORI funding awards also includes CER studies exploring questions about the value of screening for financial hardship to improve patient-centered outcomes for individuals with advanced cancer, training to increase shared decision making to improve patient experiences during labor, screening approaches for post-traumatic stress disorder in obstetrics clinics, and strategies to care for patients experiencing intimate partner violence.

Several studies will contribute data and strategies on how to optimize use of care delivery approaches to achieve greater equity in and access to care as well as better outcomes among historically underserved populations.

As generating evidence is not the end of the process to improve health outcomes, PCORI also supports efforts to promote the uptake of PCORI-funded CER findings in clinical practice. One of the new awards funds a project to implement a telepsychiatry model of care to serve primary care patients with more complex psychiatric disorders.

In addition, PCORI approved more than $6 million to fund six studies to improve methods for conducting CER and nearly $7 million for four studies that will strengthen the evidence base to inform researchers on how to optimize engagement of patients and other health care decision makers throughout the design and conduct of patient-centered CER.

"PCORI invests in studies focused on methodology and the science of engagement because it takes rigorously designed and conducted comparative clinical effectiveness research – using evidence-based approaches – to generate reliable results," said Harv Feldman, M.D., MSCE, PCORI's deputy executive director for patient-centered research programs. "PCORI also funds projects to encourage uptake of results from PCORI-funded comparative clinical effectiveness research to promote trustworthy findings reaching those whom they can help the most."

Details of these newly funded studies and projects are available on PCORI's website. All award funding has been approved pending final PCORI contractual considerations. Since 2010, PCORI has invested more than $4.5 billion to fund patient-centered CER and research-related projects.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research reveals decline in childhood mortality extended US women's lifespan by a year